Demystifying therapeutic potential of medicinal plants against chikungunya virus
- PMID: 34854411
- PMCID: PMC8641736
- DOI: 10.4103/ijp.IJP_81_20
Demystifying therapeutic potential of medicinal plants against chikungunya virus
Abstract
Viral infections are posing a great threat to humanity for the last few years. Among these, Chikungunya which is a mosquito-borne viral infection has produced enormous epidemics around the world after been rebounded. Although this infection shows a low mortality rate, patients suffer from fever, arthralgia, and maculopapular rashes, which reduce the quality of life for several weeks to years. The currently available treatments only provide symptomatic relief based on analgesics, antipyretics, and anti-inflammatory drugs which are nonspecific without satisfactory results. Medicinal plants are a widely accepted source of new molecules for the treatment of infectious diseases including viral infections. The scientific reports, primarily focusing on the anti-chikungunya activity of plant extracts, natural origin pure compounds, and their synthetic analog published from 2011 to 2021, were selected from PubMed, Google Scholar, and Scopus by using related keywords like anti-chikungunya plants, natural antivirals for Chikungunya. The present review decodes scientific reports on medicinal plants against chikungunya virus (CHIKV) infection and demystifies the potential phytoconstituents which reveals that the screening of flavonoids containing plants and phytochemicals showing efficacy against other arbovirus infections, may prove as a potential lead for drug development against CHIKV. The present article also outlines pathogenesis, clinical aspects, molecular virology, and diagnostic approaches of CHIKV infection.
Keywords: Anti-chikungunya plants; Flavonoids; antiviral therapy; chikungunya virus; clinical aspects; molecular virology; natural antivirals; pathogenesis.
Conflict of interest statement
None
Figures
Similar articles
-
Evaluation of medicinal herbs for Anti-CHIKV activity.Virology. 2019 Jul;533:45-49. doi: 10.1016/j.virol.2019.04.007. Epub 2019 Apr 29. Virology. 2019. PMID: 31082733
-
Antiviral Strategies Against Chikungunya Virus.Methods Mol Biol. 2016;1426:243-53. doi: 10.1007/978-1-4939-3618-2_22. Methods Mol Biol. 2016. PMID: 27233277 Free PMC article.
-
In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses.Front Cell Infect Microbiol. 2022 Apr 7;12:866452. doi: 10.3389/fcimb.2022.866452. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35463636 Free PMC article.
-
Recent advances in phytocompounds as potential Chikungunya virus non-structural protein 2 protease antagonists: A systematic review.Phytomedicine. 2025 Jan;136:156359. doi: 10.1016/j.phymed.2024.156359. Epub 2024 Dec 29. Phytomedicine. 2025. PMID: 39756312
-
Antivirals against Chikungunya Virus: Is the Solution in Nature?Viruses. 2020 Feb 29;12(3):272. doi: 10.3390/v12030272. Viruses. 2020. PMID: 32121393 Free PMC article. Review.
Cited by
-
Design of therapeutic siRNAs for potential application to infection with chikungunya virus.Heliyon. 2025 Jan 10;11(2):e41824. doi: 10.1016/j.heliyon.2025.e41824. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39897885 Free PMC article.
-
Development and Application of Treatment for Chikungunya Fever.Res Rep Trop Med. 2022 Dec 16;13:55-66. doi: 10.2147/RRTM.S370046. eCollection 2022. Res Rep Trop Med. 2022. PMID: 36561535 Free PMC article. Review.
-
Targeted in vitro gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework.Front Bioeng Biotechnol. 2022 Dec 14;10:1003448. doi: 10.3389/fbioe.2022.1003448. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36601387 Free PMC article.
-
Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation.Front Microbiol. 2023 Jan 5;13:1073419. doi: 10.3389/fmicb.2022.1073419. eCollection 2022. Front Microbiol. 2023. PMID: 36687601 Free PMC article.
-
Exploration of potential inhibitors against chikungunya envelope: an in-silico clue.In Silico Pharmacol. 2025 Apr 7;13(1):55. doi: 10.1007/s40203-025-00351-3. eCollection 2025. In Silico Pharmacol. 2025. PMID: 40207105
References
-
- Ledoux A, Cao M, Jansen O, Mamede L, Campos PE, Payet B, et al. Antiplasmodial, anti-Chikungunya virus and antioxidant activities of 64 endemic plants from the Mascarene Islands. Int J Antimicrob Agents. 2018;52:622–8. - PubMed
-
- Shanmugaraj B, Malla A, Ramalingam S. Epidemiology, clinical features and transmission of re-emerging arboviral infection Chikungunya. Asian Pac J Trop Biomed. 2019;9:135–9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical